Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Correction: A next generation...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.

Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.

[This corrects the article DOI: 10.1371/journal.pntd.0008459.].

Bibliographic Details
Main Authors: Federico Napolitano, Rossella Merone, Adele Abbate, Virginia Ammendola, Emma Horncastle, Francesca Lanzaro, Marialuisa Esposito, Alessandra Maria Contino, Roberta Sbrocchi, Andrea Sommella, Joshua D Duncan, Joseph Hinds, Richard A Urbanowicz, Armin Lahm, Stefano Colloca, Antonella Folgori, Jonathan K Ball, Alfredo Nicosia, Benjamin Wizel, Stefania Capone, Alessandra Vitelli
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-04-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009348&type=printable
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009348&type=printable

Similar Items

  • Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
    by: Alessandra Vitelli, et al.
    Published: (2017-12-01)
  • Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
    by: Green, C, et al.
    Published: (2015)
  • A monovalent chimpanzee adenovirus Ebola vaccine — preliminary report
    by: Rampling, T, et al.
    Published: (2015)
  • Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
    by: Ewer, K, et al.
    Published: (2013)
  • A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA
    by: Ewer (nee Russell), K, et al.
    Published: (2016)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs